Literature DB >> 23410263

Strategy to target the substrate binding site of SET domain protein methyltransferases.

Kong T Nguyen1, Fengling Li, Gennadiy Poda, David Smil, Masoud Vedadi, Matthieu Schapira.   

Abstract

Protein methyltransferases (PMTs) are a novel gene family of therapeutic relevance involved in chromatin-mediated signaling and other biological mechanisms. Most PMTs are organized around the structurally conserved SET domain that catalyzes the methylation of a substrate lysine. A few potent chemical inhibitors compete with the protein substrate, and all are anchored in the channel recruiting the methyl-accepting lysine. We propose a novel strategy to design focused chemical libraries targeting the substrate binding site, where a limited number of warheads each occupying the lysine-channel of multiple enzymes would be decorated by different substituents. A variety of sequence and structure-based approaches used to analyze the diversity of the lysine channel of SET domain PMTs support the relevance of this strategy. We show that chemical fragments derived from published inhibitors are valid warheads that can be used in the design of novel focused libraries targeting other PMTs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410263     DOI: 10.1021/ci300596x

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

1.  Dynamic behavior of the post-SET loop region of NSD1: Implications for histone binding and drug development.

Authors:  Sarah E Graham; Sara E Tweedy; Heather A Carlson
Journal:  Protein Sci       Date:  2016-03-31       Impact factor: 6.725

2.  Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds.

Authors:  Sandeep Sundriyal; Nicholas A Malmquist; Joachim Caron; Scott Blundell; Feng Liu; Xin Chen; Nitipol Srimongkolpithak; Jian Jin; Susan A Charman; Artur Scherf; Matthew J Fuchter
Journal:  ChemMedChem       Date:  2014-07-09       Impact factor: 3.466

3.  Structural insights into binding of small molecule inhibitors to Enhancer of Zeste Homolog 2.

Authors:  Marko Kalinić; Mire Zloh; Slavica Erić
Journal:  J Comput Aided Mol Des       Date:  2014-08-20       Impact factor: 3.686

4.  Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a.

Authors:  Nitipol Srimongkolpithak; Sandeep Sundriyal; Fengling Li; Masoud Vedadi; Matthew J Fuchter
Journal:  Medchemcomm       Date:  2014-09-11       Impact factor: 3.597

5.  Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity.

Authors:  Sandeep Sundriyal; Patty B Chen; Alexandra S Lubin; Gregor A Lueg; Fengling Li; Andrew J P White; Nicholas A Malmquist; Masoud Vedadi; Artur Scherf; Matthew J Fuchter
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

6.  Mimicking H3 Substrate Arginine in the Design of G9a Lysine Methyltransferase Inhibitors for Cancer Therapy: A Computational Study for Structure-Based Drug Design.

Authors:  M Ramya Chandar Charles; Mu-Chun Li; Hsing-Pang Hsieh; Mohane Selvaraj Coumar
Journal:  ACS Omega       Date:  2021-02-22

7.  Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization.

Authors:  Obdulia Rabal; Andrea Castellar; Julen Oyarzabal
Journal:  J Cheminform       Date:  2018-07-21       Impact factor: 5.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.